View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
ACPS|29 May 2018

Clinical Trial Management

ACPS relies on more than 20 years of hands-on experience in providing dedicated customised high-level services for the cost and time-efficient planning, conduct, analysis and reporting of Phase I-II clinical trials. For Phase III trials, ACPS provides customised services for central clinical trial coordination such as quality management; pharmacovigilance; investigator training and support, including set-up of trial-specific interactive webpages; and regulatory compliance, including trial master file (TMF) management.

ACPS relies on more than 20 years of experience in providing dedicated, full or partial, high-level services for the time and cost-efficient planning, conduct, analysis and reporting of clinical trials (CT).

CTs are an ultimate test of the development hypothesis that conditions can be identified. A novel medicinal product can be shown to be a safe and efficacious treatment option. Therefore, CTs and the documentation of their orderly planning, conduct, analysis and reporting are essential in the regulatory profiling of new drug products and substances.

CTs expose trial participants to risks and inconvenience with little (while time-limited) or no (while placebo-treated) individual medication-related benefit. This constraint is particularly obvious in early clinical development when investigating healthy subjects or investigating patients with out-of-scope doses.

Therefore, a favourable benefit:risk-relation requires minimising individual risk and maximising group-ethical benefit (for the future treatment of other patients).

The need to optimise and survey the benefit-risk relation of CTs is reflected by mandatory risk-based quality standards of orderly trial conduct, such as the WMA Declaration of Helsinki and good clinical practice (GCP), and the public sanctioning of the compliance with these standards by competent authorities and ethics committees.

For clinical Phase I-II trials, ACPS provides customised A-Z services from trial design and protocol conception to trial reporting & EudraCT-upload thereof.

For clinical Phase III trials, ACPS provides customised services for central CT-coordination, quality management, pharmacovigilance (including set-up and management of data safety monitoring boards), investigator training and support (including set-up of trial-specific interactive web pages), and regulatory compliance, including electronic trial management file (TMF) management.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Clinical Trials Arena